LogicBio Therapeutics

LogicBio Therapeutics

Edit info

  • Founded: 2014
  • Location: Lexington, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin1/Clin2
  • Therapy area: Genetic diseases
  • Drug types: GEN, RAR, PED
  • Lead product: GeneRide platform
  • Funding: $48M stock Oct 2020; $80.5M IPO Oct 2018; $45M B Jun 2017; $4M Jan 2016


logicbio.com

linkedin.com

job board


Business:

Gene Therapy

Drug notes:

Also sAAVy platform

About:

LogicBio Therapeutics is developing genetic medicines to fight against rare pediatric diseases. LogicBio is pioneering safer, site-specific genome editing technology to provide durable therapies using their GeneRide proprietary platform. LogicBio has currently designed GeneRide to identify liver-targeted therapies - the platform uses a synthetic viral vector to deliver the corrective transgene to a patient's cell into the highly-expressed albumin locus. By using a 2A peptide, both the corrective transgene and albumin are produced as separate protein products and modify albumin with a small tag to monitor GeneRide activity. LogicBio’s initial product candidates will address diseases by targeting the liver, but the company is looking to expand to other tissues.

LogicBio Therapeutics
Career Counselor
Pittsburgh, PA|10 days ago
Apply
LogicBio Therapeutics
Security Guard
Pittsburgh, PA|10 days ago
LogicBio Therapeutics
****** ******** *******, *********
**********, **|10 days ago
LogicBio Therapeutics
****** *********** **********
**********, **|40 days ago
LogicBio Therapeutics
********* ****
**********, **|100+ days ago
LogicBio Therapeutics
****
**********, **|100+ days ago
LogicBio Therapeutics
Registered Nurse (RN)
Pittsburgh, PA|100+ days ago


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com